Viscosupplementation is a joint injection technique that places hyaluronic acid (HA) directly into the knee to supplement the natural lubricating fluid that thins out as osteoarthritis progresses. Patients often describe it as a "gel shot," though the formulation and injection protocol vary by product. For people with mild-to-moderate knee osteoarthritis who have not found adequate relief from oral medication or physical therapy, a qualified physician may discuss viscosupplementation as one option among several in a broader treatment plan.
What Happens to Joint Fluid in Osteoarthritis?
Healthy synovial fluid contains hyaluronic acid, a naturally occurring polysaccharide that gives the fluid its viscous, cushioning quality. As osteoarthritis develops, the concentration and molecular weight of HA in the joint commonly decrease, and the fluid becomes thinner and less able to absorb the mechanical load of daily movement. This reduction is one of several changes — alongside cartilage thinning and low-grade inflammation — that contribute to the stiffness and discomfort associated with knee OA. Viscosupplementation aims to replace some of this lost viscosity, though it does not reverse the underlying joint degeneration.
How Is a Viscosupplementation Injection Performed?
The procedure is typically performed in an outpatient clinical setting. After identifying the injection site, often with ultrasound guidance to confirm accurate joint placement, the clinician cleans the skin and introduces a needle into the joint space. If joint effusion is present, fluid may first be aspirated to reduce pressure and improve subsequent HA distribution. The hyaluronic acid solution is then injected, and the process from preparation to completion generally takes only a few minutes. Some protocols use a single injection, while others involve a short series of weekly injections, depending on the specific product and physician preference.
Is Viscosupplementation Painful?
Most patients report mild discomfort comparable to a routine injection, similar to how HA is administered in dermal applications. Localized soreness, mild swelling, or warmth at the injection site can occur for a day or two afterward. Applying a cold compress and limiting strenuous activity immediately following the injection are commonly recommended. Symptoms significantly beyond mild soreness, such as marked swelling, redness, or fever, warrant a call to the treating clinician.
Who Might Be a Candidate for This Approach?
Viscosupplementation is generally considered for patients with radiographically confirmed knee osteoarthritis, typically in earlier to moderate stages, who have had an insufficient response to conservative measures such as weight management, activity modification, or oral analgesics. It is not typically used as a first-line treatment before these conservative approaches have been tried, and it is not appropriate for joints with active infection or significant skin breakdown near the injection site. A qualified physician determines suitability based on imaging, symptom severity, and overall health status.
Hyaluronic Acid Technology in Aesthetic and Joint Applications
Hyaluronic acid is used across multiple areas of medicine, including both joint viscosupplementation and dermal applications for skin quality. INVAMED's VitaFLEX Hyaluronic Acid Intradermal is formulated for intradermal use to support skin hydration and volume rather than joint injection, illustrating how the same base molecule is engineered differently depending on the clinical target and tissue. Readers interested in HA-based dermal technology can review the VitaFLEX product page for details relevant to skin applications: https://invamed.com/product/vitaflex-hyaluronic-acid-intradermal. Formulations intended specifically for intra-articular use differ in molecular weight, cross-linking, and viscosity from dermal products, so the two should not be considered interchangeable.
What Results Might Be Expected?
Any symptom improvement following viscosupplementation is individual and cannot be guaranteed. Some patients report reduced stiffness and improved comfort during movement in the weeks following treatment, while others notice minimal change. Effects, when present, are typically not permanent, and repeat courses are sometimes considered later if initial benefit fades and the joint remains appropriate for the approach. Viscosupplementation is used to supplement joint lubrication — it is not a cure for osteoarthritis and does not regenerate cartilage.
Does viscosupplementation replace the need for knee replacement surgery?
Not necessarily. It is generally used for earlier or moderate osteoarthritis rather than advanced, bone-on-bone disease. A qualified physician evaluates joint imaging and symptom severity to determine whether viscosupplementation, other conservative care, or surgical evaluation is more appropriate.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.